Literature DB >> 24384697

Virus antibody dynamics in primary and secondary dengue infections.

Tanvi P Gujarati1, G Ambika.   

Abstract

Dengue viral infections show unique infection patterns arising from its four serotypes, (DENV-1,2,3,4). Its effects range from simple fever in primary infections to potentially fatal secondary infections. We analytically and numerically analyse virus dynamics and humoral response in a host during primary and secondary dengue infection for long periods using micro-epidemic models. The models presented here incorporate time delays, antibody dependent enhancement, a dynamic switch and a correlation factor between different DENV serotypes. We find that the viral load goes down to undetectable levels within 7-14 days as is observed for dengue infection, in both cases. For primary infection, the stability analysis of steady states shows interesting dependence on the time delay involved in the production of antibodies from plasma cells. We demonstrate the existence of a critical value for the immune response parameter, beyond which the infection gets completely cured. For secondary infections with a different serotype, the homologous antibody production is enhanced due to the influence of heterologous antibodies. The antibody production is also controlled by the correlation factor, which is a measure of similarities between the different DENV serotypes involved. Our results agree with clinically observed humoral responses for primary and secondary infections.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24384697     DOI: 10.1007/s00285-013-0749-4

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  44 in total

Review 1.  Neutralization and antibody-dependent enhancement of dengue viruses.

Authors:  Scott B Halstead
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

Review 2.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

Review 3.  Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms.

Authors:  Alan L Rothman
Journal:  Nat Rev Immunol       Date:  2011-07-15       Impact factor: 53.106

4.  Competitive exclusion in a vector-host model for the dengue fever.

Authors:  Z Feng; J X Velasco-Hernández
Journal:  J Math Biol       Date:  1997-05       Impact factor: 2.259

Review 5.  Important advances in the field of anti-dengue virus research.

Authors:  Justin G Julander; Stuart T Perry; Sujan Shresta
Journal:  Antivir Chem Chemother       Date:  2011

Review 6.  Development of new vaccines against dengue fever and Japanese encephalitis.

Authors:  R M Kinney; C Y Huang
Journal:  Intervirology       Date:  2001       Impact factor: 1.763

Review 7.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 8.  Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.

Authors:  Sansanee Noisakran; Guey Chuen Perng
Journal:  Exp Biol Med (Maywood)       Date:  2008-04

9.  Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2.

Authors:  R T He; B L Innis; A Nisalak; W Usawattanakul; S Wang; S Kalayanarooj; R Anderson
Journal:  J Med Virol       Date:  1995-04       Impact factor: 2.327

10.  Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.

Authors:  S B Halstead
Journal:  Yale J Biol Med       Date:  1970-04
View more
  11 in total

1.  Minimal within-host dengue models highlight the specific roles of the immune response in primary and secondary dengue infections.

Authors:  Rotem Ben-Shachar; Katia Koelle
Journal:  J R Soc Interface       Date:  2015-02-06       Impact factor: 4.118

2.  Mathematical Modelling of Immune Parameters in the Evolution of Severe Dengue.

Authors:  M K Premaratne; S S N Perera; G N Malavige; Saroj Jayasinghe
Journal:  Comput Math Methods Med       Date:  2017-02-15       Impact factor: 2.238

3.  Simulation Model for Dynamics of Dengue with Innate and Humoral Immune Responses.

Authors:  S D Perera; S S N Perera
Journal:  Comput Math Methods Med       Date:  2018-04-11       Impact factor: 2.238

4.  Modelling the impact of antibody-dependent enhancement on disease severity of Zika virus and dengue virus sequential and co-infection.

Authors:  Biao Tang; Yanni Xiao; Beate Sander; Manisha A Kulkarni; Jianhong Wu
Journal:  R Soc Open Sci       Date:  2020-04-15       Impact factor: 2.963

5.  Within-host mechanisms of immune regulation explain the contrasting dynamics of two helminth species in both single and dual infections.

Authors:  Chiara Vanalli; Lorenzo Mari; Lorenzo Righetto; Renato Casagrandi; Marino Gatto; Isabella M Cattadori
Journal:  PLoS Comput Biol       Date:  2020-11-23       Impact factor: 4.475

6.  Within Host Dynamics of SARS-CoV-2 in Humans: Modeling Immune Responses and Antiviral Treatments.

Authors:  Indrajit Ghosh
Journal:  SN Comput Sci       Date:  2021-10-12

7.  Within-host viral dynamics of dengue serotype 1 infection.

Authors:  Hannah E Clapham; Vianney Tricou; Nguyen Van Vinh Chau; Cameron P Simmons; Neil M Ferguson
Journal:  J R Soc Interface       Date:  2014-07-06       Impact factor: 4.118

Review 8.  Arbovirosis and potential transmission blocking vaccines.

Authors:  Berlin Londono-Renteria; Andrea Troupin; Tonya M Colpitts
Journal:  Parasit Vectors       Date:  2016-09-23       Impact factor: 3.876

Review 9.  Challenges in dengue research: A computational perspective.

Authors:  José Lourenço; Warren Tennant; Nuno R Faria; Andrew Walker; Sunetra Gupta; Mario Recker
Journal:  Evol Appl       Date:  2017-11-05       Impact factor: 5.183

10.  Burden of cytokines storm on prognosis of SARS-CoV-2 infection through immune response: dynamic analysis and optimal control with immunomodulatory therapy.

Authors:  Payal Rana; Sudipa Chauhan; Anuj Mubayi
Journal:  Eur Phys J Spec Top       Date:  2022-01-27       Impact factor: 2.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.